These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22369906)

  • 21. Spasticity.
    Behari M
    Neurol India; 2002 Sep; 50(3):235-7. PubMed ID: 12391445
    [No Abstract]   [Full Text] [Related]  

  • 22. Spasticity: a review.
    Young RR
    Neurology; 1994 Nov; 44(11 Suppl 9):S12-20. PubMed ID: 7970006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam.
    Turski L; Stephens DN
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1215-20. PubMed ID: 8263782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle relaxants--the current position in the treatment of spasticity in orthopedics.
    Zygmunt M; Sapa J
    Ortop Traumatol Rehabil; 2015; 17(4):423-30. PubMed ID: 26468180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New therapies for spastic movement disorders].
    Benecke R; Patejdl R
    MMW Fortschr Med; 2009 Oct; 151 Suppl 3():118-22. PubMed ID: 20623938
    [No Abstract]   [Full Text] [Related]  

  • 26. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological analysis of the mode of action of muscle relaxants in spasticity.
    Delwaide PJ
    Ann Neurol; 1985 Jan; 17(1):90-5. PubMed ID: 3985591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of spastic syndromes].
    Hartmann-von Monakow K
    Bibl Psychiatr Neurol; 1969; 139():114-23. PubMed ID: 4257720
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of sirdalud in painful muscle tonic syndromes].
    Damulin IV
    Ter Arkh; 1997; 69(10):68-72. PubMed ID: 9471796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacotherapy of spinal spasticity: a decade of progress. II. Therapeutics.
    Segatore M; Miller M
    SCI Nurs; 1995 Mar; 12(1):2-7. PubMed ID: 7792578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologic and clinical monitoring of spastic hypertonia.
    Hinderer SR; Dixon K
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):733-46. PubMed ID: 11723863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke.
    Stamenova P; Koytchev R; Kuhn K; Hansen C; Horvath F; Ramm S; Pongratz D
    Eur J Neurol; 2005 Jun; 12(6):453-61. PubMed ID: 15885050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke].
    Stamenova P; Koytchev R; Kuhn K; Hanasen C; Horvath F; Ramm S; Pongratz D
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(1):34-42. PubMed ID: 16457132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Physical and other methods therapy of the spasticity in children].
    Swierczyńska A; Renata K; Jaworek M
    Przegl Lek; 2007; 64(11):974-7. PubMed ID: 18409416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW; Bugaresti J; Shellenberger K; Sheremata W; Martinez-Arizala A
    Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spasticity.
    Dietz V; Sinkjaer T
    Handb Clin Neurol; 2012; 109():197-211. PubMed ID: 23098714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Measuring outcome in spasticity rehabilitation].
    Fheodoroff K; Wissel J; Entner T; Freimüller M
    Wien Klin Wochenschr; 2001; 113 Suppl 4():11-5. PubMed ID: 15506046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tonic stretch reflex threshold as a measure of spasticity: implications for clinical practice.
    Calota A; Levin MF
    Top Stroke Rehabil; 2009; 16(3):177-88. PubMed ID: 19632962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Simpson DM; Gracies JM; Graham K; Hallett M; Miyasaki J; Naumann M; Russman B; Simpson L; So Y
    Neurology; 2009 Sep; 73(9):736-7; author reply 737-8. PubMed ID: 19728407
    [No Abstract]   [Full Text] [Related]  

  • 40. Antispasticity medications.
    Nance PW; Young RR
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):337-55, viii. PubMed ID: 10370935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.